Oculis Holding AG (OCS) Shares Outstanding (2021 - 2026)
Oculis Holding AG (OCS) posted quarterly Shares Outstanding (Entity) of $45.7 million for Q4 2025, up 29.29% year-over-year from $35.3 million in Q4 2024, and little changed quarter-over-quarter from $45.8 million in Q3 2025.
Oculis Holding AG (OCS) Shares Outstanding (2021 - 2026) Analysis & Trends
Oculis Holding AG's Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $45.7 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 29.29% year-over-year to $45.7 million; the TTM figure through Dec 2025 stood at $45.7 million (up 29.29% YoY), while the FY2025 annual figure was $45.7 million, up 29.29% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $45.7 million, roughly flat from $45.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $45.8 million in Q3 2025, with the low at $2.4 million in Q4 2021.
- The 5-year median for Shares Outstanding (Entity) is $31.8 million (2023), against an average of $25.8 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) grew 7.63% in 2022, then soared 949.52% in 2023.
- Oculis Holding AG's Shares Outstanding (Entity) stood at $2.4 million in 2021, then grew by 7.63% to $2.6 million in 2022, then soared by 900.18% to $26.2 million in 2023, then surged by 35.14% to $35.3 million in 2024, then climbed by 29.29% to $45.7 million in 2025.
- Business Quant data shows OCS's Shares Outstanding (Entity) at $45.7 million in Q4 2025, $45.8 million in Q3 2025, and $45.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Oculis Holding AG | 879.09 Mn | 590.21 Mn | - | 61.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.27 Mn |
| Mar 31, 2026 | 52.24 Mn |
| Dec 31, 2025 | 52.24 Mn |
| Sep 30, 2025 | 52.36 Mn |
| Jun 30, 2025 | 52.29 Mn |
| Mar 31, 2025 | 40.41 Mn |
| Dec 31, 2024 | 40.41 Mn |
| Sep 30, 2024 | 41.81 Mn |
| Jun 30, 2024 | 40.54 Mn |
| Mar 31, 2024 | 36.62 Mn |
| Dec 31, 2023 | 29.90 Mn |
| Sep 30, 2023 | 36.33 Mn |
| Jun 30, 2023 | 33.57 Mn |
| Mar 31, 2023 | 12.88 Mn |
| Dec 31, 2022 | 2.99 Mn |
| Sep 30, 2022 | 3.46 Mn |
| Jun 30, 2022 | 3.39 Mn |
| Dec 31, 2021 | 2.78 Mn |